ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. Alliança Saúde e Participações S.A. Share Price
Equities
AALR3
BRAALRACNOR6
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.37 BRL | +33.43% |
|
-8.61% | +28.56% |
| Sales 2022 | 1.09B 199M 16.61B | Sales 2023 | 1.18B 216M 18.06B | Capitalization | 1.23B 225M 18.8B |
|---|---|---|---|---|---|
| Net income 2022 | -228M -41.79M -3.49B | Net income 2023 | -228M -41.79M -3.49B | EV / Sales 2022 | 3.37 x |
| Net Debt 2022 | 1.11B 204M 17.07B | Net Debt 2023 | 1.09B 200M 16.7B | EV / Sales 2023 | 1.97 x |
| P/E ratio 2022 |
-11.2
x | P/E ratio 2023 |
-5.4
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.14% |
More Fundamentals
* Assessed data
More news
Latest transcript on Alliança Saúde e Participações S.A.
More press releases
| 1 day | +33.43% | ||
| 1 week | -8.61% | ||
| Current month | +28.68% | ||
| 1 month | +33.03% | ||
| 3 months | +50.06% | ||
| 6 months | +52.63% | ||
| Current year | +28.56% |
1 week
13.15
17.32
1 month
9.6317.32
Current year
6.1517.32
1 year
6.1524.32
3 years
6.1524.32
5 years
6.1524.32
10 years
6.1524.32
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 28/23/28 | |
| Compliance Officer | - | 20/22/20 | |
| Chief Tech/Sci/R&D Officer | - | 15/22/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pedro Grossi
BRD | Director/Board Member | 80 | 25/21/25 |
| Chairman | 73 | 14/22/14 | |
| Director/Board Member | 50 | 28/23/28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/24/16 | 13.37 | +33.43% | 47 100 |
| 15/24/15 | 14.04 | +1.37% | 64,400 |
| 12/24/12 | 13.85 | -18.86% | 191,400 |
| 11/24/11 | 17.07 | +4.53% | 80,400 |
| 10/24/10 | 16.33 | +11.62% | 134,500 |
Delayed Quote Sao Paulo, July 16, 2024 at 10:17 pm IST
More quotes
Centro de Imagem Diagnosticos SA, also known as Alliar, is a Brazil-based company engaged in the provision of healthcare services. The Company focuses on managing medical and diagnostic laboratories. The Company offers medical and diagnostic imaging services, such as biopsy, bone densitometry, laboratory tests, digital mammography, Doppler echocardiography, positron emission tomography (PET) scan for oncology, X-radiation (X-rays), magnetic resonance imaging (MRI), computer tomography (CT), prenatal tests and ultrasounds. The Company operates a number of units in the states of Parana, Para, Minas Gerais, Bahia, Espirito Santo, Rio de Janeiro, Rio Grande do Norte and Sao Paulo, among others, Brazil.
Calendar
08/08/2024
- Q2 2024 Earnings Release
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +28.56% | 304M | |
| -18.17% | 8.55B | |
| +86.22% | 4.63B | |
| +16.31% | 2.98B | |
| -3.15% | 2.65B | |
| -5.56% | 1.89B | |
| -53.27% | 1.81B | |
| -13.36% | 1.56B | |
| +21.59% | 1.27B | |
| -47.96% | 1.07B |
- Stock Market
- Equities
- AALR3 Stock
